Skip to main content
Livermore
Livermore
ZHEN

Dimensional Fund Advisors LP

SEC CIK
0000354204
Latest filing
Aug 11, 2026

ADMA holding history

Adma Biologics, Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ADMA overviewAll 13F holders of ADMAFull Q2 2026 holdings

Shares (Q2 2026)
3,606,208
Value
$30.2M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ADMA by Dimensional Fund Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,606,208$30.2M<0.1%−1,399,273−28.0%ReducedHolders
Q1 20265,005,481$45.1M<0.1%+169,843+3.5%AddedHolders
Q4 20254,835,638$88.2M<0.1%+37,364+0.8%AddedHolders
Q3 20254,798,274$70.3M<0.1%+35,199+0.7%AddedHolders
Q2 20254,763,075$86.7M<0.1%−97,239−2.0%ReducedHolders
Q1 20254,860,314$96.4M<0.1%+191,994+4.1%AddedHolders
Q4 20244,668,320$80.1M<0.1%+643,661+16.0%AddedHolders
Q3 20244,024,659$80.4M<0.1%+866,699+27.4%AddedHolders
Q2 20243,157,960$35.3M<0.1%−440,076−12.2%ReducedHolders
Q1 20243,598,036$23.7M<0.1%+106,975+3.1%AddedHolders
Q4 20233,491,061$15.8M<0.1%+561,243+19.2%AddedHolders
Q3 20232,929,818$10.5M<0.1%+1,651,433+129.2%AddedHolders
Q2 20231,278,385$4.72M<0.1%+1,222,854+2,202.1%AddedHolders
Q1 202355,531$183.8K<0.1%00.0%UnchangedHolders
Q4 202255,531$215.0K<0.1%−2,648−4.6%ReducedHolders
Q3 202258,179$141.0K<0.1%−5,783−9.0%ReducedHolders
Q2 202263,962$126.0K<0.1%+6,290+10.9%AddedHolders
Q1 202257,672$106.0K<0.1%00.0%UnchangedHolders
Q4 202157,672$81.0K<0.1%−45,546−44.1%ReducedHolders
Q3 2021103,218$117.0K<0.1%−36,095−25.9%ReducedHolders
Q2 2021139,313$223.0K<0.1%−12,400−8.2%ReducedHolders
Q1 2021151,713$267.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.